COVID-19 Vaccine Side Effect Tracker - MedShadow Foundation
| X2S1 Stock | EUR 13.10 0.20 1.55% |
Roughly 55% of SINOPHARM GROUP's stockholders are presently thinking to get in. The analysis of current outlook of investing in SINOPHARM GROUP 15ON suggests that some traders are interested regarding SINOPHARM GROUP's prospects. The current market sentiment, together with SINOPHARM GROUP's historical and current headlines, can help investors time the market. In addition, many technical investors use SINOPHARM GROUP 15ON stock news signals to limit their universe of possible portfolio assets.
SINOPHARM GROUP stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of SINOPHARM daily returns and investor perception about the current price of SINOPHARM GROUP 15ON as well as its diversification or hedging effects on your existing portfolios.
SINOPHARM |
COVID-19 Vaccine Side Effect Tracker MedShadow Foundation
Read at news.google.com
 |
SINOPHARM GROUP Fundamental Analysis
We analyze SINOPHARM GROUP's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SINOPHARM GROUP using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SINOPHARM GROUP based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
SINOPHARM GROUP is rated below average in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
SINOPHARM GROUP 15ON Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with SINOPHARM GROUP stock to make a market-neutral strategy. Peer analysis of SINOPHARM GROUP could also be used in its relative valuation, which is a method of valuing SINOPHARM GROUP by comparing valuation metrics with similar companies.
Peers
SINOPHARM GROUP Related Equities
| X2S1 | SINOPHARM GROUP | 1.55 | ||||
| X2S | Sinopharm Group | 1.54 | ||||
| CLH | Cardinal Health | 0.94 | ||||
| 59Z | MEDIPAL HOLDINGS | 0.70 | ||||
| ABG | AmerisourceBergen | 0.37 | ||||
| S1R | Shanghai Pharmaceuticals | 0.63 | ||||
| PBV | Prestige Consumer | 0.66 | ||||
| PD2 | Patterson Companies | 1.34 | ||||
| HS2 | Henry Schein | 2.60 |
Complementary Tools for SINOPHARM Stock analysis
When running SINOPHARM GROUP's price analysis, check to measure SINOPHARM GROUP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SINOPHARM GROUP is operating at the current time. Most of SINOPHARM GROUP's value examination focuses on studying past and present price action to predict the probability of SINOPHARM GROUP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SINOPHARM GROUP's price. Additionally, you may evaluate how the addition of SINOPHARM GROUP to your portfolios can decrease your overall portfolio volatility.
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |